Lovima® 75 microgram film-coated tablets (desogestrel) - PL 42807/0002.

Indications: Oral contraception for women of childbearing age including adolescents.

Posology: One tablet every day continuously; 24 hours between tablets. First tablet taken on the first day of menstrual bleeding.

Contraindications: Active venous thromboembolic disorder. Presence or history of severe hepatic disease. Known or suspected sex-steroid sensitive malignancies. Undiagnosed vaginal bleeding. Hypersensitivity to any ingredients. Peanut or soya allergy.

Precautions: Pregnancy should be excluded, contains lactose, not for patients with rare hereditary problems of galactose intolerance, the Lapp lactase deficiency, or glucose-galactose malabsorption. Caution in patients with: a history of breast cancer, diabetes, liver cancer or chloasma or depressed mood arising during use. Efficacy may be reduced with missed tablets, gastrointestinal disturbances, or concomitant medications. Stop if sustained hypertension not controlled.

Side effects: Common (≥1/100 to <1/10) breast pain; depressed mood; mood altered; libido decreased; menstrual cycle irregularities; nausea; acne; weight increased, headache. Uncommon (≥1/1,000 to <1/100) vaginal infections, contact lens intolerance, vomiting, alopecia, dysmenorrhoea, ovarian cyst, fatigue. Rare (≥1/10,000 to <1/1,000) rash, urticaria, erythema nodosum.

MA holder: Maxwellia Ltd, Alderley Park, Alderley Edge, SK10 4TG

Classification: P. RRP (ex.5% VAT): 28 tablets £9.48 or 84 tablets £19.00.

Date: August 2023.